FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048796490> ?p ?o ?g. }

• W3048796490 abstract "Abstract Background Signals of adverse drug reactions (ADRs) form the basis of some regulatory risk-minimization actions in pharmacovigilance. Reviews of limited scope have highlighted that such signals are mostly supported by reports of ADRs or multiple types of evidence. The time that elapses between a report of a suspected ADR and the communication of a signal has not been systematically characterized. Neither has the features of reports of suspected ADRs that authors used to support putative causal relationships, although difficulties with establishing causal relationships between medicinal products and adverse events have been highlighted. The objectives of this study will be to describe the evidence underpinning signals in pharmacovigilance, the features of reports of ADRs supporting signals, and the time that it takes to communicate a signal. Methods We shall retrieve records from PubMed, EMBASE, Web of Science, and PsycINFO (from inception onwards), without language/design restrictions, and apply backward citation screening. We shall hand-search the websites of 35 regulatory agencies/authorities, restricted publications from the Uppsala Monitoring Centre, and drug bulletins. Signals will be requested from the competent stakeholder, if absent from websites. We shall use VigiBase, the World Health Organization’s Global Individual Case Safety Report database, to determine the dates on which ADRs were reported. We shall manage records using EndNote (v. 8.2); one reviewer will screen titles/abstracts and full texts, a second will cross-validate the findings, and a third will arbitrate disagreements. Data will be charted via the Systematic Reviews Data Repository, following the same procedures as for data retrieval. Evidence will be categorized according to the Oxford Centre for Evidence-Based Medicine Levels of Evidence. Features of reports of ADRs will be coded. Tables will display frequencies of types of evidence and features of reports of ADRs. We shall use plots or pictograms (if appropriate) to represent the time from the first report of a suspected ADR to a signal. Discussion We expect the findings from this review will allow a better understanding of global patterns of similarities or differences in terms of supporting evidence and timing of communications and identify relevant research questions for future systematic reviews. Systematic review registration osf.io/a4xns" @default.
• W3048796490 created "2020-08-18" @default.
• W3048796490 creator A5015118134 @default.
• W3048796490 creator A5062680588 @default.
• W3048796490 creator A5081151451 @default.
• W3048796490 date "2020-08-13" @default.
• W3048796490 modified "2023-09-26" @default.
• W3048796490 title "Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature" @default.
• W3048796490 cites W112113049 @default.
• W3048796490 cites W130378437 @default.
• W3048796490 cites W1585480050 @default.
• W3048796490 cites W1990223736 @default.
• W3048796490 cites W1995418742 @default.
• W3048796490 cites W2005357164 @default.
• W3048796490 cites W2015487160 @default.
• W3048796490 cites W2017851316 @default.
• W3048796490 cites W2027102963 @default.
• W3048796490 cites W2027158091 @default.
• W3048796490 cites W2057123862 @default.
• W3048796490 cites W2064716383 @default.
• W3048796490 cites W2067978628 @default.
• W3048796490 cites W2075950485 @default.
• W3048796490 cites W2076859891 @default.
• W3048796490 cites W2082276693 @default.
• W3048796490 cites W2084154288 @default.
• W3048796490 cites W2085089735 @default.
• W3048796490 cites W2090621988 @default.
• W3048796490 cites W2091538045 @default.
• W3048796490 cites W2119741970 @default.
• W3048796490 cites W2153972688 @default.
• W3048796490 cites W2157584018 @default.
• W3048796490 cites W2161374186 @default.
• W3048796490 cites W2163471236 @default.
• W3048796490 cites W2167186282 @default.
• W3048796490 cites W2169205464 @default.
• W3048796490 cites W2194417674 @default.
• W3048796490 cites W2269807470 @default.
• W3048796490 cites W2330496155 @default.
• W3048796490 cites W2341757727 @default.
• W3048796490 cites W2613479577 @default.
• W3048796490 cites W2738680803 @default.
• W3048796490 cites W2803144468 @default.
• W3048796490 cites W2891378911 @default.
• W3048796490 cites W2895048798 @default.
• W3048796490 cites W2941887701 @default.
• W3048796490 cites W2971814634 @default.
• W3048796490 doi "https://doi.org/10.1186/s13643-020-01429-z" @default.
• W3048796490 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7425142" @default.
• W3048796490 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32791982" @default.
• W3048796490 hasPublicationYear "2020" @default.
• W3048796490 type Work @default.
• W3048796490 sameAs 3048796490 @default.
• W3048796490 citedByCount "2" @default.
• W3048796490 countsByYear W30487964902021 @default.
• W3048796490 countsByYear W30487964902022 @default.
• W3048796490 crossrefType "journal-article" @default.
• W3048796490 hasAuthorship W3048796490A5015118134 @default.
• W3048796490 hasAuthorship W3048796490A5062680588 @default.
• W3048796490 hasAuthorship W3048796490A5081151451 @default.
• W3048796490 hasBestOaLocation W30487964901 @default.
• W3048796490 hasConcept C142724271 @default.
• W3048796490 hasConcept C17744445 @default.
• W3048796490 hasConcept C197934379 @default.
• W3048796490 hasConcept C199360897 @default.
• W3048796490 hasConcept C199539241 @default.
• W3048796490 hasConcept C201305675 @default.
• W3048796490 hasConcept C204787440 @default.
• W3048796490 hasConcept C2778012447 @default.
• W3048796490 hasConcept C2779473830 @default.
• W3048796490 hasConcept C2779549880 @default.
• W3048796490 hasConcept C2780035454 @default.
• W3048796490 hasConcept C2780385302 @default.
• W3048796490 hasConcept C2780542314 @default.
• W3048796490 hasConcept C2993432071 @default.
• W3048796490 hasConcept C39549134 @default.
• W3048796490 hasConcept C41008148 @default.
• W3048796490 hasConcept C57658597 @default.
• W3048796490 hasConcept C71924100 @default.
• W3048796490 hasConcept C98274493 @default.
• W3048796490 hasConceptScore W3048796490C142724271 @default.
• W3048796490 hasConceptScore W3048796490C17744445 @default.
• W3048796490 hasConceptScore W3048796490C197934379 @default.
• W3048796490 hasConceptScore W3048796490C199360897 @default.
• W3048796490 hasConceptScore W3048796490C199539241 @default.
• W3048796490 hasConceptScore W3048796490C201305675 @default.
• W3048796490 hasConceptScore W3048796490C204787440 @default.
• W3048796490 hasConceptScore W3048796490C2778012447 @default.
• W3048796490 hasConceptScore W3048796490C2779473830 @default.
• W3048796490 hasConceptScore W3048796490C2779549880 @default.
• W3048796490 hasConceptScore W3048796490C2780035454 @default.
• W3048796490 hasConceptScore W3048796490C2780385302 @default.
• W3048796490 hasConceptScore W3048796490C2780542314 @default.
• W3048796490 hasConceptScore W3048796490C2993432071 @default.
• W3048796490 hasConceptScore W3048796490C39549134 @default.
• W3048796490 hasConceptScore W3048796490C41008148 @default.
• W3048796490 hasConceptScore W3048796490C57658597 @default.
• W3048796490 hasConceptScore W3048796490C71924100 @default.
• W3048796490 hasConceptScore W3048796490C98274493 @default.
• W3048796490 hasIssue "1" @default.
• W3048796490 hasLocation W30487964901 @default.

• next